Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
-2,131.3%
Operating Margin
-64.21%
Net Margin
2,303.2%

Efficiency Metrics

Revenue per Expense Ratio
0.04
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
2,305.4%
Income Tax Rate
0.00%
EPS
4.9600000000

Balance Sheet Analysis

Current Ratio
155.82
Cash Ratio
617.64
Working Capital
$8.67M
Debt to Equity
0.00
Debt to Assets
0.02%
Equity Ratio
86.32%

Cash Flow Analysis

Operating Cash Flow Ratio
0.00%
Free Cash Flow Ratio
0.00%
CapEx to Revenue
0.00%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
0.00%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
106.02%
Net Income
235.99%
EPS
250.30%
Operating Income
96.21%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
-12.79%
Operating Cash Flow
0.00%
Free Cash Flow
0.00%

Balance Sheet Health

Assets
-0.45%
Debt
-17.65%
Book Value per Share
13.15%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
0.00%
Shares Outstanding
-9.44%

Long Term Trends

3Y Revenue/Share
-82.02%
5Y Revenue/Share
102.67%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%